Search results
Moderna's billionaire CEO reaped nearly $400 million last year. He also got a raise.
Washington Post via Yahoo News· 1 year agoStéphane Bancel, chief executive of Moderna, had a good year in 2022, exercising stock options that...
Moderna's Bancel defends COVID-19 vaccine price at Sanders hearing
Yahoo Finance· 1 year agoModerna's CEO Stéphane Bancel faced off with Sen. Bernie Sanders and others of the Senate HELP...
Moderna will break even in 2026: CEO Stéphane Bancel
Yahoo Finance via AOL· 6 months agoModerna (MRNA) missed Wall Street expectations in the third quarter earnings report released Thursday, as it continues rightsizing the company and...
Moderna CEO faces Sen. Sanders in COVID-19 vaccine pricing hearing Wednesday
Yahoo Finance· 1 year agoModerna (MRNA) CEO Stéphane Bancel will join a panel in front of the Senate Health, Education, Labor...
Democrats blast Moderna CEO over plans to quadruple price of COVID-19 vaccine
The Hill via Yahoo News· 1 year agoDemocratic senators lashed out at Moderna CEO Stéphane Bancel in a Thursday hearing over his...
Moderna Employees Should Use ChatGPT at Least 20 Times a Day, CEO Says
Gizmodo via Yahoo News· 3 days agoStéphane Bancel, CEO of Moderna at the Fast Company Innovation Festival on September 21, 2023 in New...
Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough...
Business Insider via Yahoo News· 1 year agoStéphane Bancel, the CEO of Moderna.Nancy Lane/MediaNews Group/Boston Herald Moderna's cancer...
Moderna's CEO To Appear Before Senate On Quadrupling COVID-19 Vaccine Prices
Benzinga via Yahoo Finance· 1 year agoModerna Inc's (NASDAQ: MRNA) CEO, Stéphane Bancel, will testify next month on its plans to raise the...
Senators press Moderna CEO on COVID-19 vaccine price hike
Associated Press via Yahoo News· 1 year agoModerna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine...
This Prediction From Moderna's CEO Should Eliminate Investors' Biggest Worry
Motley Fool· 2 years agoModerna (NASDAQ: MRNA) shares have dropped about 40% this year for one big reason. Investors are...